EducationUC Irvine Researchers Advance Targeted Chemotherapy to Protect Healthy Cells
A New Experimental Prodrug Developed at UC Irvine Is Designed to Activate Only When It Encounters Elevated Protein-Destroying Activity Inside Cancer Cells.
Search the full Irvine Source archive, browse by topic, or explore what's trending.
Share this #cancer-treatment feed
EducationA New Experimental Prodrug Developed at UC Irvine Is Designed to Activate Only When It Encounters Elevated Protein-Destroying Activity Inside Cancer Cells.
BusinessTAE Life Sciences Partners with Foxsemicon Integrated Technology Inc. to Boost Production of Its Targeted Radiation Therapy.
EducationA New Approach Designed at UC Irvine Activates Potent Cancer Drugs Only Inside Tumor Cells, Aiming to Reduce Damage to Healthy Tissue.
EducationA UC Irvine Study Suggests Repurposing Existing Drugs Could Mitigate Severe Neurological Complications of the Powerful Cancer Therapy.
EducationA New Approach Combining Mathematical Modeling with Biological Experiments Sheds Light on Why Many Advanced Melanoma Patients Experience Disease Recurrence After Initial Immunotherapy Success.
EducationA New Framework Developed at UC Irvine Targets Biological Processes to Reduce Severe Neurological Complications From a Powerful Cancer Treatment.
EducationA New Framework From UC Irvine Outlines How Repurposing Existing Drugs Could Mitigate Serious Neurological Complications Associated with Advanced Cancer Treatment.